The Real Housewives of New Jersey star spoke exclusively to HELLO! about her menopause struggles, life on Ozempic and refreshing relationship goals ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

Novo Nordisk’s blockbuster GLP-1 diabetes drug Ozempic led to improvements in some measures of alcohol use disorder in a ...

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

the active ingredients in Ozempic and Mounjaro, respectively. One woman injected one dose of semaglutide for her diabetes and woke up the next morning blind in her left eye. This prompted her to ...

Ozempic has skyrocketed in popularity as both ... healthcare providers may explore whether a dosage adjustment or a different medication option is a better fit for the patient.

Rapid fat loss from GLP-1 medications like Ozempic can lead to 'Ozempic face', characterized by hollow cheeks and sagging skin. Drinking water, eating a protein-rich diet, and practicing face yoga ...